Cargando…

A double-blind, placebo-controlled trial of the efficacy and safety of two doses of azelastine hydrochloride in perennial allergic rhinitis

BACKGROUND: Azelastine hydrochloride (AZE) is a selective, non-sedating H1 antagonist with anti-inflammatory and mast cell stabilizing properties, which can be used as an alternative to intranasal corticosteroids. The objective of this study was to evaluate the efficacy of the new formulation of 0.1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bousquet, Jean, Klimek, Ludger, Kuhl, Hans-Christian, Nguyen, Duc Tung, Ramalingam, Rajesh Kumar, Canonica, G. W., Berger, William E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Allergy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619846/ https://www.ncbi.nlm.nih.gov/pubmed/37920410 http://dx.doi.org/10.3389/falgy.2023.1244012

Ejemplares similares

Efficacy and tolerability of levocabastine and azelastine nasal sprays for the treatment of allergic rhinitis
por: Mösges, Ralph, et al.
Publicado: (1995)

Comparative study of the efficacy and safety of intranasal azelastine hydrochloride and fluticasone furoate in the treatment of allergic rhinitis
por: Chennakeshavaraju, Nandish, et al.
Publicado: (2020)

A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic Rhinitis
por: Zhou, Bing, et al.
Publicado: (2023)

Erratum: “Comparative study of the efficacy and safety of intranasal azelastine hydrochloride and fluticasone furoate in the treatment of allergic rhinitis”
Publicado: (2021)

Diagnostic Tools in Allergic Rhinitis
por: Testera-Montes, Almudena, et al.
Publicado: (2021)

Precision Medicine in Mite Allergic Rhinitis
por: González-Pérez, Ruperto, et al.
Publicado: (2021)

Allergic Rhinitis in Childhood and the New EUFOREA Algorithm
por: Scadding, Glenis Kathleen, et al.
Publicado: (2021)

Determinants of uncontrolled allergic rhinitis in Kinshasa hospitals
por: Kakobo, Patricia K., et al.
Publicado: (2023)

Mechanism and clinical evidence of immunotherapy in allergic rhinitis
por: De Carli, Marco, et al.
Publicado: (2023)

Long-term safety and efficacy of rupatadine in Japanese patients with perennial allergic rhinitis: a 52-week open-label clinical trial
por: Okubo, Kimihiro, et al.
Publicado: (2019)

Intranasal antihistamines and corticosteroids in the treatment of allergic rhinitis: a systematic review and meta-analysis protocol
por: Sousa-Pinto, Bernardo, et al.
Publicado: (2023)

Azelastine hydrochloride and budesonide (nasal sprays): effectiveness combination therapy monitored by acoustic rhinometry and clinical symptom score in the treatment of allergic rhinitis
por: Fabbri, Natalia Zanellato, et al.
Publicado: (2013)

Control of allergic rhinitis in four latin american countries: Rinola study
por: Silva, Diana L, et al.
Publicado: (2022)

Effectiveness of twice daily azelastine nasal spray in patients with seasonal allergic rhinitis
por: Horak, Friedrich
Publicado: (2008)

Pattern of Aeroallergen Sensitization and Quality of Life in Adult Thai Patients With Allergic Rhinitis
por: Katel, Puspalal, et al.
Publicado: (2021)

Allergic Rhinitis: What Do We Know About Allergen-Specific Immunotherapy?
por: Boonpiyathad, Tadech, et al.
Publicado: (2021)

The impact of propolis on clinical manifestations and specific IgE levels against salsola in perennial-allergic rhinitis patients
por: Jabbari-Azad, Farahzad, et al.
Publicado: (2023)

Cholinergic Synapse Pathway Gene Polymorphisms Associated With Late-Phase Responses in Allergic Rhinitis
por: Samra, Simranjit K., et al.
Publicado: (2021)

154 A 26-Week Study Evaluating the Safety and Efficacy of Ciclesonide Hydrofluoralkane Nasal Aerosol in Subjects With Perennial Allergic Rhinitis
por: Berger, William, et al.
Publicado: (2012)

Azelastine hydrochloride, a dual-acting anti-inflammatory ophthalmic solution, for treatment of allergic conjunctivitis
por: Williams, Patricia B, et al.
Publicado: (2010)

146 A 6-Week Study of the Efficacy and Safety of Ciclesonide Hydrofluoroalkane Nasal Aerosol in the Relief of Nasal Symptoms of Perennial Allergic Rhinitis
por: Mohar, Dale, et al.
Publicado: (2012)

The Effect of Seasonal Priming on Specific Inhalation Challenges With Birch and Grass Allergen Among Persons With Allergic Rhinitis
por: Ørby, Pia V., et al.
Publicado: (2021)

Factors predicting the outcome of allergen-specific nasal provocation test in children with grass pollen allergic rhinitis
por: Barreto, M., et al.
Publicado: (2023)

Back to basics: likelihood ratios for olive and grass pollen specific IgE in seasonal allergic rhinitis
por: Manzanares, Bárbara, et al.
Publicado: (2023)

The Multidirectional Effect of Azelastine Hydrochloride on Cervical Cancer Cells
por: Trybus, Ewa, et al.
Publicado: (2022)

Allergic rhinitis and asthma symptoms in a real-life study of MP-AzeFlu to treat multimorbid allergic rhinitis and asthma
por: Price, David, et al.
Publicado: (2020)

Dropouts From Sublingual Immunotherapy and the Transition to Subcutaneous Immunotherapy in House Dust Mite-Sensitized Allergic Rhinitis Patients
por: Chen, Huan, et al.
Publicado: (2022)

Protective effects of inhalation of essential oils from Mentha piperita leaf on tight junctions and inflammation in allergic rhinitis
por: Park, Nayoung, et al.
Publicado: (2022)

Patient Satisfaction and Sensory Attributes of Nasal Spray Treatments of Olopatadine Hydrochloride/Mometasone Furoate Monohydrate and Azelastine Hydrochloride/Fluticasone Propionate for Allergic Rhinitis in Australia – An Observational Real-World Clinical Study
por: Fifer, Simon, et al.
Publicado: (2023)

Exploring the latest understanding on the role of immune mediators, genetic and environmental factors in pathogenesis of allergic rhinitis: a systematic review
por: Albloushi, Shaimaa, et al.
Publicado: (2023)

373 Alteration of Smell in Patients with Persistent Allergic Rhinitis
por: De Barayazarra, Susana, et al.
Publicado: (2012)

The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey
por: Price, David, et al.
Publicado: (2015)

Der p 1 Disrupts the Epithelial Barrier and Induces IL-6 Production in Patients With House Dust Mite Allergic Rhinitis
por: Ogi, Kazuhiro, et al.
Publicado: (2021)

Higher efficacy of rupatadine 20 mg and 10 mg versus placebo in patients with perennial allergic rhinitis: a pooled responder analysis
por: Valero, Antonio, et al.
Publicado: (2020)

The relationship between prebiotic intake and allergic rhinitis
por: Chang, Chao, et al.
Publicado: (2023)

MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis
por: van Weissenbruch, Ranny, et al.
Publicado: (2020)

The Comparative Bioavailability of Fluticasone and Azelastine Delivered as a Single Fixed Dose Combination (MP-AzeFlu) in Comparison to Two Different Formulations of Azelastine and Fluticasone Propionate Following Intranasal Administration in Healthy Chinese Volunteers
por: Qi, Wenyuan, et al.
Publicado: (2023)

247 Health-Related Quality of Life and Prognostic Value of Acoustic Rhinometry in Patients With Perennial Allergic Rhinitis Treated with Fix Combination of Montelukast Plus Desloratadine
por: Cingi, Cemal, et al.
Publicado: (2012)

Clinical Efficacy and Safety of Low-Level Laser Therapy in Patients with Perennial Allergic Rhinitis: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Jung, Hahn Jin, et al.
Publicado: (2021)

Role of antioxidants on the clinical outcome of patients with perennial allergic rhinitis
por: Chauhan, Bhushan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_915ak5vogbqoti9qt3t2vmrfdq